RT Journal Article
SR Electronic
T1 Occupational exposure to insulating materials and risk of coronary artery diseases
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.12.22283365
DO 10.1101/2022.12.12.22283365
A1 Moitra, Subhabrata
A1 Tabrizi, Ali Farshchi
A1 Khadour, Fadi
A1 Henderson, Linda
A1 Melenka, Lyle
A1 Lacy, Paige
YR 2022
UL http://medrxiv.org/content/early/2022/12/13/2022.12.12.22283365.abstract
AB Background Although previous reports link exposure to insulating materials with an increased risk of mesothelioma and chronic respiratory diseases, studies evaluating their associations with the risk of coronary artery diseases (CAD) are lacking.Aims We aimed at evaluating associations between exposure to insulating materials and the 10-year risk of CAD among insulators.Methods In this cross-sectional study, we recruited 643 adults (≥18 years) who were full-time insulators from the Local 110 Heat and Frost Insulators and Allied Workers Union in Edmonton, Alberta. We obtained demographic information, personal and family history, and job-exposure history including experience (years) and types of exposure to insulating materials. Clinical profiling including Framingham risk scores (FRS) was assessed.Results Of all insulators, 89% were male (mean±SD age: 47±12 years), 27% had a parental history of cardiac diseases, and 22% had a comorbid chronic respiratory disease. 53% reported exposure to asbestos while 61, 82, and 94% reported exposure to ceramic fibers, fiberglass, and mineral fibers, respectively. In single-exposure multivariable regression models adjusted for experience, marital status, and body mass index (BMI), asbestos was found to be associated with higher FRS (β: 1.004; 95%CI: 0.003 to 2.00). The association remained consistent in multi-exposure models and a higher association between asbestos exposure and FRS among insulators with comorbid chronic respiratory disease.Conclusions Our study demonstrates that apart from cancer and chronic respiratory diseases, asbestos exposure may also have a cardiac effect and thus warranting the need for systematic surveillance to protect workers from the adverse effects of these materials.What is already known about this subjectInsulating materials, particularly asbestos and man-made vitreous fibres (MMVFs) are well-known occupational hazards, and both long- and short-term exposure to these materials have been found to associate with increased risk of chronic respiratory diseases and cancers, and mortality due to those diseases.Evidence of the cardiovascular effects of asbestos and other MMVFs is scanty and only limited to empirical retrospective mortality studies; however, most of those studies produced mixed results on the roles of asbestos and other MMVFs on cardiovascular health.It is important to learn the effects of these insulating materials on organ systems other than the lungs in order to identify the potential health hazards of these materials and upgrade surveillance and current safety measures to protect the workers.What this study addsWe studied over 800 workers who were exposed to a variety of insulating materials including asbestos and MMVFs and our results indicate an association between asbestos exposure and increased Framingham risk score (10-year estimated risk of cardiovascular diseases).Further long-term prospective studies are needed to assess the short and long-term effects of these exposures on disease development, particularly among non-smokers. Furthermore, the quantitation of workplace exposure is also important to understand the dose-response nature of these exposures.What impact this may have on practice or policyOur findings provide new evidence of asbestos-associated increased risk of cardiovascular diseases, which underscores the need for a more rigorous systematic monitoring of the health of workers.Our findings also warrant a more comprehensive knowledge of the physicians, particularly occupational physicians regarding the possible occupational risk factors for chronic diseases, including cardiovascular diseases.Our findings may provide a basis for further research and amendment of policies related to the workers’ health, protection, compensation, and benefits.TEASER TEXT Previous studies have demonstrated that exposure to insulating materials including asbestos is associated with an increased risk of mesothelioma and other chronic respiratory diseases. However, these materials have not been systematically investigated as possible risk factors for coronary artery diseases (CAD). Our study is the first to demonstrate an association between exposure to insulating materials, particularly asbestos, and an increased 10-year predicted risk of CAD. These findings warrant further control of exposure to these materials.Competing Interest StatementSM reports personal fees from Synergy Respiratory & Cardiac Care (Canada), Permanyer Inc. (Spain), Elsevier Inc. (USA), Apollo Gleneagles Hospital (India), and Institute of Allergy-Kolkata (India), outside the submitted work. PL reports grants from the Wellness of Workers programme, Local 110 Heat and Frost Insulators and Allied Workers, and Synergy Respiratory Care Limited (Canada) that supported this work; and personal fees from AstraZeneca (Canada) and GlaxoSmithKline (Canada) outside this work. The other authors do not have any conflict of interest to declare with this work.Funding StatementThis research was Supported by grants from the Wellness of Workers (WoW) Program, Local 110 Heat & Frost Insulators & Allied Workers, and Synergy Respiratory Care Limited. However, the funder was not involved in the design of the study and did not influence the dissemination of the study outcomes.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study has been conducted as per the Declaration of Helsinki and is compliant with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, and approved by the Health Research Ethics Board of Alberta (HREBA.CTC-17-0067) and Health Research Ethics Board (Pro00079792), University of Alberta. All participants provided signed informed consent forms before taking part in the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.